Recent 8-K filings for HCSG

• July 22, 2026, 7:04 AM ET earnings materiality 0.75 positive item 2.02item 9.01

  HCSG Q2 2026: Revenue $470.8M, EPS $0.32, reaffirms mid-single-digit growth outlook

  Revenue of $470.8M; Environmental segment $213.2M (13.3% margin), Dietary $257.6M (7.5% margin).

• April 22, 2026, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01 ◈ Earnings Releases

  HCSG Q1 revenue $462.8M (+3.4%), EPS $0.37, reiterates 2026 mid-single-digit growth outlook

  Revenue $462.8M, up 3.4% YoY; diluted EPS $0.37; net income $26.1M.

• April 13, 2026, 7:59 PM ET debt materiality 0.60 neutral item 1.01item 2.03item 9.01 ◈ Debt Financings◈ Material Agreements

  HCSG amends credit agreement, extends revolving credit facility maturity to April 7, 2031

  Extended maturity date of $300M revolving credit facility to April 7, 2031 from prior maturity.

• February 11, 2026, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  HCSG reports Q4 EPS $0.44, FY revenue $1.84B; announces $75M buyback

  Q4 EPS $0.44, net income $31.2M; FY EPS $0.81, net income $59.1M.

• October 22, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  HCSG beats Q3 expectations with 8.5% revenue growth; EPS of $0.59 includes $0.36 ERC benefit

  Q3 revenue $464.3M (+8.5% YoY); net income $43.0M, diluted EPS $0.59 including $0.36 ERC benefit.

• July 23, 2025, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  HCSG Q2 revenue up 7.6% to $458.5M; net loss $0.44/diluted share on $0.65 Genesis charge

  Revenue $458.5M (+7.6% YoY); mid-single-digit growth guidance reaffirmed for 2025.

• July 10, 2025, 7:59 PM ET other material materiality 0.80 negative item 7.01item 9.01

  HCSG reports ~$0.62/share Q2 charge from client Genesis bankruptcy; reaffirms 2025 guidance

  Genesis HealthCare filed Chapter 11 on July 9; HCSG provides services to 164 Genesis facilities.

• April 23, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  HCSG reports Q1 revenue $447.7M (+5.7% YoY), EPS $0.23; raises FY 2025 cash flow forecast to $60-75M

  Revenue $447.7M (+5.7% YoY); diluted EPS $0.23; net income $17.2M.

• February 12, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  HCSG reports Q4 revenue $437.8M, diluted EPS $0.16; guides Q1 2025 revenue $440-450M

  Revenue $437.8M, net income $11.9M ($0.16 diluted EPS) inclusive of start-up costs.

• October 23, 2024, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  Healthcare Services Group Q3 revenue $428.1M, in line; EPS $0.19; reaffirms Q4 guidance

  Revenue $428.1M meets guidance; Q4 revenue estimate reaffirmed at $430-440M.

• July 24, 2024, 7:59 PM ET earnings materiality 0.70 neutral item 2.02item 9.01

  HCSG Q2 net loss $1.8M on $426.3M revenue; raises H2 revenue estimates

  Net loss $1.8M, diluted EPS -$0.02; includes $0.22/share charge from LaVie Chapter 11 restructuring.

• June 3, 2024, 7:59 PM ET other material materiality 0.60 negative item 7.01item 9.01

  HCSG estimates $0.20 Q2 charge from LaVie Chapter 11; reiterates 2024 cash flow

  Q2 non-cash charge of ~$0.20 per share due to LaVie Care Centers Chapter 11 filing.

• April 24, 2024, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01 ◈ Earnings Releases

  HCSG Q1 diluted EPS $0.21 beats expectations; revenue $423.4M in line; reiterates FY2024 cash flow guidance

  Diluted EPS of $0.21 (adjusted $0.22) exceeds expectations; net income $15.3M.

• February 14, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases ×2

  HCSG Q4 2023: adjusted EPS $0.20, revenue $423.8M, cash flow beats guidance

  Net income $22.6M ($0.31 diluted EPS); adjusted net income $14.6M ($0.20 adjusted EPS).

• October 25, 2023, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01 ◈ Earnings Releases

  HCSG Q3 GAAP loss $0.07/share; adjusted EPS $0.17 (up 13.3%); raises H2 cash flow guidance

  Revenue $411.4M, adjusted revenue $424.0M in line with $420-430M range; Q4 revenue guided at $420-430M.

• April 26, 2023, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01 ◈ Earnings Releases

  HCSG Q1 revenue $417.2M, adjusted EBITDA up 18% to $27.5M

  GAAP net income $12.7M ($0.17 per share); adjusted EBITDA $27.5M, up 18% YoY.

• October 19, 2022, 7:59 PM ET earnings materiality 0.65 negative item 2.02item 8.01item 9.01

  HCSG Q3 revenue $414.5M, net income $0.3M; cost of services 90.9%

  Net income of $0.3M; cost of services 90.9% impacted by $7.6M AR reserve increase.

• July 20, 2022, 7:59 PM ET earnings materiality 0.70 negative item 2.02item 8.01item 9.01

  HCSG Q2 2022 revenue $424.9M, net income $6.8M ($0.09 EPS); cost of services 89.3% due to $7M AR reserve

  Revenue $424.9M; housekeeping & laundry $199.1M, dining & nutrition $225.8M; segment margins 9.0% and 4.5%.

• April 20, 2022, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 8.01item 9.01

  HCSG Q1 2022 revenue $426.8M, net income $11.3M ($0.15 EPS); declares $0.2125 dividend

  Revenue $426.8M (housekeeping/laundry $201.7M, dining/nutrition $225.1M).

• February 9, 2022, 6:59 PM ET earnings materiality 0.65 negative item 2.02item 8.01item 9.01

  HCSG Q4 revenue $420.4M, EPS $0.03; margins pressured by labor inflation

  Revenue $420.4M; net income $2.1M ($0.03 EPS); housekeeping & laundry $200.0M, dining $220.4M.

• October 20, 2021, 7:59 PM ET earnings materiality 0.70 negative item 2.02item 5.02item 8.01item 9.01 ◈ executive_change

  HCSG Q3 revenue $415.6M, net income $9.5M ($0.13 EPS); cites labor inflation, Delta surge headwinds

  Revenue $415.6M, net income $9.5M ($0.13 diluted EPS); direct costs 87.8% of revenue.

• August 24, 2021, 7:59 PM ET regulatory materiality 0.70 negative item 5.02item 8.01item 9.01 ◈ executive_change

  Healthcare Services Group settles SEC EPS probe for $6M; CFO Shea shifts to CAO role

  Agreed to pay $6.0M civil penalty to SEC for EPS calculation errors from 2014-2017; neither admitted nor denied charges.

• July 21, 2021, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 8.01item 9.01

  HCSG Q2 revenue $398.2M, EPS $0.13; $6M SEC reserve, $3M labor reserve, Genesis adjustment

  Revenue $398.2M, net income $9.6M, diluted EPS $0.13; cash flow from operations $25.3M.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.65 · Most common event earnings

10 positive 9 negative 17 neutral

source · HCSG on sec.gov